课题基金 / 基金详情

Development of plaque assay to isolate cytopathic HCV clones

Development of plaque assay to isolate cytopathic HCV clones
开发噬菌斑测定法来分离细胞病变的 HCV 克隆
批准号:
21590832
负责人:
OOOKA Shinya
金额:
$2.91万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

OOOKA Shinya的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
HCV-JFH1 yields subclones that develop cytopathic plaques(Sekine-Osajima Y, et al., Virology 2008 ; 371 : 71). Here, we investigated viral amino acid substitutions in cytopathic mutant HCV-JFH1 clones and their characteristics in vitro and in vivo. The mutant viruses with individual C2441S, P2938S or R2985P signature substitutions, and with all three substitutions, showed significantly higher intracellular replication efficiencies and greater cytopathic effects than the parental JFH1 in vitro. The mutant HCV-inoculated mice showed significantly higher serum HCV RNA and higher level of expression of ER stress-related proteins in early period of infection. At 8 weeks post inoculation, these signature mutations had reverted to the wild type sequences. HCV-induced cytopathogenicity is associated with the level of intracellular viral replication and is determined by certain amino acid substitutions in HCV-NS5A and NS5B regions. The cytopathic HCV clones exhibit high replication competence in vivo but may be eliminated during the early stages of infection
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MMP-2 and MMP-14 derived from donor cells enhance therapeutic efficacy of liver cell transplantation in mice
供体细胞来源的 MMP-2 和 MMP-14 增强小鼠肝细胞移植的治疗效果
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Kakinuma S, Sakamoto N, Watanabe M, et al.]
通讯作者: et al.
Association of gene expression involving innate immunity and genetic variation in IL28B with antiviral response
IL28B 中涉及先天免疫和遗传变异的基因表达与抗病毒反应的关联
DOI: --
发表时间: 2011
期刊: Hepatology
影响因子: 13.5
作者: [Asahina Y, Sakamoto N, et al.]
通讯作者: et al.
DOI: 10.1016/j.virol.2010.07.041
发表时间: 2010-11
期刊: Virology
影响因子: 3.7
作者: [G. Suda;N. Sakamoto;Yasuhiro Itsui;M. Nakagawa;Megumi Tasaka-Fujita;Yusuke Funaoka;Takako Watanabe;S. Nitta;Kei Kiyohashi;Seishin Azuma;S. Kakinuma;K. Tsuchiya;M. Imamura;N. Hiraga;K. Chayama;Mamoru Watanabe]
通讯作者: G. Suda;N. Sakamoto;Yasuhiro Itsui;M. Nakagawa;Megumi Tasaka-Fujita;Yusuke Funaoka;Takako Watanabe;S. Nitta;Kei Kiyohashi;Seishin Azuma;S. Kakinuma;K. Tsuchiya;M. Imamura;N. Hiraga;K. Chayama;Mamoru Watanabe
DOI: 10.3892/ijmm.2011.622
发表时间: 2011-05
期刊: International journal of molecular medicine
影响因子: 5.4
作者: [Mako Toyoda;A. Kitaoka;Kazuyuki Machida;T. Nishinakagawa;R. Yada;M. Kohjima;Masaki Kato;K. Kotoh]
通讯作者: Mako Toyoda;A. Kitaoka;Kazuyuki Machida;T. Nishinakagawa;R. Yada;M. Kohjima;Masaki Kato;K. Kotoh
43
    Suppression of hepatitis C virus replication by cyclosporine A
    • 批准号:
      16590580
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2004
    • 负责人:
      OOOKA Shinya
    • 依托单位: